Business Wars Daily cover image

Mounjaro Beats Ozempic in Study

Business Wars Daily

00:00

The Results of a Study Comparing Munjaro and Ozempic for Weight Loss

Analyzing the effectiveness of Munjaro and Ozempic for weight loss, discussing Eli Lilly's new drug Zepbound and Novo Nordisk's weight loss version of Ozempic called Wegovi, and highlighting the ongoing competition between the two companies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app